SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001372514-23-000160
Filing Date
2023-11-09
Accepted
2023-11-09 07:02:00
Documents
51
Period of Report
2023-11-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20231109.htm   iXBRL 8-K 26701
2 EX-99.1 kiorapharmaoverviewq4202.htm EX-99.1 33201
6 kiorapharmaoverviewq4202001.jpg GRAPHIC 45587
7 kiorapharmaoverviewq4202002.jpg GRAPHIC 180441
8 kiorapharmaoverviewq4202003.jpg GRAPHIC 69723
9 kiorapharmaoverviewq4202004.jpg GRAPHIC 67926
10 kiorapharmaoverviewq4202005.jpg GRAPHIC 68909
11 kiorapharmaoverviewq4202006.jpg GRAPHIC 78793
12 kiorapharmaoverviewq4202007.jpg GRAPHIC 38878
13 kiorapharmaoverviewq4202008.jpg GRAPHIC 86047
14 kiorapharmaoverviewq4202009.jpg GRAPHIC 88007
15 kiorapharmaoverviewq4202010.jpg GRAPHIC 85636
16 kiorapharmaoverviewq4202011.jpg GRAPHIC 87884
17 kiorapharmaoverviewq4202012.jpg GRAPHIC 92963
18 kiorapharmaoverviewq4202013.jpg GRAPHIC 75607
19 kiorapharmaoverviewq4202014.jpg GRAPHIC 91628
20 kiorapharmaoverviewq4202015.jpg GRAPHIC 65930
21 kiorapharmaoverviewq4202016.jpg GRAPHIC 92822
22 kiorapharmaoverviewq4202017.jpg GRAPHIC 72098
23 kiorapharmaoverviewq4202018.jpg GRAPHIC 81430
24 kiorapharmaoverviewq4202019.jpg GRAPHIC 91181
25 kiorapharmaoverviewq4202020.jpg GRAPHIC 90994
26 kiorapharmaoverviewq4202021.jpg GRAPHIC 69272
27 kiorapharmaoverviewq4202022.jpg GRAPHIC 83389
28 kiorapharmaoverviewq4202023.jpg GRAPHIC 62903
29 kiorapharmaoverviewq4202024.jpg GRAPHIC 115213
30 kiorapharmaoverviewq4202025.jpg GRAPHIC 94888
31 kiorapharmaoverviewq4202026.jpg GRAPHIC 82393
32 kiorapharmaoverviewq4202027.jpg GRAPHIC 107719
33 kiorapharmaoverviewq4202028.jpg GRAPHIC 82458
34 kiorapharmaoverviewq4202029.jpg GRAPHIC 37895
35 kiorapharmaoverviewq4202030.jpg GRAPHIC 77834
36 kiorapharmaoverviewq4202031.jpg GRAPHIC 95039
37 kiorapharmaoverviewq4202032.jpg GRAPHIC 77278
38 kiorapharmaoverviewq4202033.jpg GRAPHIC 99150
39 kiorapharmaoverviewq4202034.jpg GRAPHIC 33011
40 kiorapharmaoverviewq4202035.jpg GRAPHIC 89545
41 kiorapharmaoverviewq4202036.jpg GRAPHIC 75847
42 kiorapharmaoverviewq4202037.jpg GRAPHIC 54314
43 kiorapharmaoverviewq4202038.jpg GRAPHIC 32870
  Complete submission text file 0001372514-23-000160.txt   4370281

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20231109.xsd EX-101.SCH 1919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20231109_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20231109_pre.xml EX-101.PRE 13058
45 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20231109_htm.xml XML 2814
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 231389988
SIC: 2834 Pharmaceutical Preparations